Drug Shortage Report for RELPAX
| Report ID | 193008 |
| Drug Identification Number | 02256290 |
| Brand name | RELPAX |
| Common or Proper name | RELPAX |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ELETRIPTAN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-17 |
| Estimated end date | Unknown |
| Actual end date | 2023-07-06 |
| Shortage status | Resolved |
| Updated date | 2023-07-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-07-13 | French | Compare |
| v7 | 2023-07-13 | English | Compare |
| v6 | 2023-06-27 | French | Compare |
| v5 | 2023-06-27 | English | Compare |
| v4 | 2023-06-13 | French | Compare |
| v3 | 2023-06-13 | English | Compare |
| v2 | 2023-05-25 | French | Compare |
| v1 | 2023-05-25 | English | Compare |
Showing 1 to 8 of 8